In line with previous literature, we also report increased prevalences of comorbidities typically characterized by T2 mechanisms—IgE sensitization, eczema, and rhinitis—in both the asthma and control groups with T2 features. This evidence concerns the gene IGHE and Eczematoid dermatitis.